Explore Monopar Therapeutics Inc.'s 8-K filing from February 19, 2025, revealing crucial updates that impact stakeholders and stock performance. Get the latest on MNPR.
Explore DiaMedica Therapeutics Inc.'s important 8-K filing, highlighting significant events, stock details, and compliance with XBRL standards. Stay informed on DMAC updates.
Explore Harmony Biosciences Holdings, Inc.'s 8-K filing dated February 25, 2025, detailing stock info, entity data, and SEC compliance.
Discover Bright Minds Biosciences Inc.'s Form 6-K filing details, including insights on compliance, exhibits, and financial updates as of February 24, 2025.
Explore Lixte Biotechnology Holdings, Inc.'s 8-K report filed on February 19, 2025. Discover vital updates, stock information, and insights into their financial activities.
Discover crucial updates from Arcus Biosciences, Inc. in their 8-K report filed on February 18, 2025. Learn about their biopharmaceutical operations and stock details.
Discover crucial updates from Charles River Laboratories (CRL) in their 8-K report filed on February 19, 2025. Stay informed on corporate changes affecting stakeholders.
Discover Purple Biotech's latest financial report highlighting the advancement of NT219 into Phase 2 trials for Head and Neck Cancer, crucial for investors and market positioning.
Explore GeneDx Holdings Corp.'s latest 8-K filing, revealing critical stock and warrant details, including pricing and classifications for investors.
Explore Bright Minds Biosciences Inc.'s Form 6-K, detailing Q1 2024 financials, management insights, and CEO/CFO certifications.
Explore the latest 8-K report for Intelligent Bio Solutions Inc. detailing company info, stock performance, and more as of February 13, 2025. Stay informed on INBS updates!
On February 12, 2025, Inmed Pharmaceuticals Inc. filed an 8-K report revealing essential updates for shareholders regarding its NASDAQ status and more.